AW

Alpha Wave Ventures

North America, Florida, United States, Miami

Description

Alpha Wave Ventures is an investment firm.

Investor Profile

Alpha Wave Ventures has made 18 investments, with 2 in the past 12 months and 72% as lead.

Stage Focus

  • Series C (33%)
  • Series B (17%)
  • Series D (17%)
  • Series A (11%)
  • Series F (6%)
  • Series H (6%)
  • Seed (6%)
  • Series Unknown (6%)

Country Focus

  • United States (67%)
  • India (17%)
  • United Kingdom (6%)
  • United Arab Emirates (6%)
  • Hong Kong (6%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Biopharma
  • Medical Device
  • Pharmaceutical
  • Artificial Intelligence (Ai)
  • Therapeutics
  • Neuroscience
  • Precision Medicine
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Alpha Wave Ventures frequently co-invest with?

Angelini Ventures
Europe, Lazio, Italy, Rome
Co-Investments: 1
Sectoral Asset Management
North America, Quebec, Canada, Montréal
Co-Investments: 2
Bristol-Myers Squibb
North America, New York, United States, New York
Co-Investments: 2
Abu Dhabi Growth Fund
Asia, Abu Dhabi, United Arab Emirates, Abu Dhabi
Co-Investments: 2
JDRF T1D Fund
North America, Massachusetts, United States, Boston
Co-Investments: 1
Tao Capital Partners
North America, California, United States, San Francisco
Co-Investments: 2
Lumira Ventures
North America, Ontario, Canada, Toronto
Co-Investments: 2
Alpha Wave Global
North America, Florida, United States, Miami
Co-Investments: 3
Roche Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1

Which angels does Alpha Wave Ventures often collaborate with?

George Godula
Asia, Shanghai, China, Shanghai
Shared Deals: 1

What are some of recent deals done by Alpha Wave Ventures?

Metsera

New York, New York, United States

Metsera is a biopharmaceutical company that develops medicines for obesity and metabolic diseases.

BiopharmaHealth CareMedicalPharmaceutical
Series BNov 13, 2024
Amount Raised: $215,000,000
HistoSonics

Plymouth, Minnesota, United States

HistoSonics specializes in developing non-invasive medical devices, interventional radiology, and surgical robotics.

Health CareMedicalMedical Device
Series DAug 15, 2024
Amount Raised: $102,000,000
Biolinq

San Diego, California, United States

Biolinq develops a wearable biosensor platform that is capable of measuring blood level information.

BiotechnologyHealth CareMedical DeviceWearables
Series DApr 4, 2024
Amount Raised: $58,000,000
Hunch

Dubai, Dubai, United Arab Emirates

Hunch is a social discovery app that creates social interactions and honest discussions through open and anonymous conversations and polls.

ChatbotInformation and Communications Technology (ICT)Social MediaSocial Network
Series AMar 6, 2024
Amount Raised: $23,000,000
Attralus

San Francisco, California, United States

Attralus is a biopharmaceutical company focusing on creating transformative medicines to improve the lives of patients.

BiopharmaBiotechnologyHealth CareMedical
Series BFeb 6, 2024
Amount Raised: $56,000,000
Cour Pharmaceuticals Development

Skokie, Illinois, United States

Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.

BiotechnologyPharmaceuticalTherapeutics
Series AJan 30, 2024
Amount Raised: $105,000,000
PierSight Space

Ahmedabad, Gujarat, India

PierSight is constructing a SAR satellite network to provide continuous monitoring for the maritime industry.

Information TechnologySoftware
SeedJan 9, 2024
Amount Raised: $5,324,999
Biryani By Kilo

Noida, Uttar Pradesh, India

Biryani By Kilo is a restaurant chain that focuses on biryanis and kebabs.

CateringFood and BeverageFood DeliveryFood Processing
Series CDec 4, 2023
Amount Raised: $8,629,798
Alto Neuroscience

Los Altos, California, United States

Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.

Artificial Intelligence (AI)BiopharmaBiotechnologyNeurosciencePrecision Medicine
Series CNov 21, 2023
Amount Raised: $45,000,000
Alto Neuroscience

Los Altos, California, United States

Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.

Artificial Intelligence (AI)BiopharmaBiotechnologyNeurosciencePrecision Medicine
Series BJan 30, 2023
Amount Raised: $25,000,000